Primordial Genetics
Claus Zieler, M.Sc., MBA is President International Markets at Astellas Pharma Singapore Pte Ltd, where he is responsible for a $1bn revenue pharmaceutical business.
He has more than 20 years of experience in different executive roles in commercial, development, and strategy functions in the pharmaceutical industry, including responsibilities for different markets in Latin America, Europe, and Asia, and for different therapeutic areas, such as oncology, cardiology, neurology, gynaecology, and dermatology.
Claus Zieler earned an MBA from INSEAD in Fontainebleau, France, as well as an M.Sc. in Molecular Biology from the University of Wisconsin, Madison, and a B.A. in Molecular Biology from Princeton University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Primordial Genetics
Primordial Genetics is a synthetic biology company founded in 2013. They are the world leader in constructive biology; a revolutionary new way of practicing biotechnology that creates novel genes from genomic building blocks to accelerate the evolution of highly efficient enzymes and microbes.